- {- item.details.type -}
- {- item.details.date -}
- {- item.details.sector -}
Limit search to:
-
{- f.title -}
- {- option.title -}
Your settings:
- {- option.title -}
DNV GL’s Precision Medicine works with partners through large-scale public-private research and innovation projects to help address the data-sharing and infrastructure needs, legal and regulatory challenges, and gaps in trust that prevent the clinical implementation of big data approaches, AI tools, and precision medicine in routine clinical care.
New technologies must fulfill appropriate safety and quality requirements before clinical adoption.
Artificial intelligence is increasingly impacting how health systems make decisions and deliver care.
We work with experts from healthcare institutions, legal and academia to identify barriers to implementation of dynamic consent, and focus on coordinating efforts to make dynamic consent a reality in clinical genetics environments
The latest position papers and reports from our strategic research precision medicine programme
Program Director, Precision Medicine Group Technology and Research
Send email